Search Results

You are looking at 21 - 30 of 173 items for :

  • Refine by Access: All x
Clear All
Full access

HSR23-113: Patient and Provider Perspectives on How COVID-19 Impacted Melanoma Care Delivery

Nadya Prood, Laura Mesana, Meaghan Roach, Rozanne Wilson, Nana Rezai, Maria Cecilia Vieira, and Suepattra G. May

Background: The COVID-19 pandemic has caused extensive disruptions to healthcare delivery, including cancer care. Immediate and long-term effects of the pandemic on melanoma care delivery have not been well elucidated. This study examined patient

Full access

HSR23-096: COVID-19 Impact and Psychosocial Well-Being Among Adults Living With Cancer: A Longitudinal Analysis

Erica E. Fortune, Victoria G. Morris, Caroline Lawrence, and Alexandra K. Zaleta

Background: COVID-19 continues to have long-lasting effects on healthcare experiences and health-related quality of life, especially for individuals who are more reliant on frequent medical services, such as those living with a cancer diagnosis

Full access

BPI22-023: Strategies to Prevent Unplanned Emergency Department (ED) Utilization in the COVID-19 Era

Raquel Reinbolt, Weihong Chase, Doris Garnett, and Penny Moore

. Strategies to divert patients away from the ED are needed, especially in the setting of COVID-19, which has disrupted usual care provision and exposed already vulnerable cancer patients to even greater risk. At the James Cancer Hospital, we have implemented

Full access

CLO22-032: Effect of COVID-19 Causing Treatment Delay in Cancer Patients Receiving Immune Checkpoint Inhibitors

Anuja Abhyankar, Abigail Chan, Ruobing Xue, Vatsala Katiyar, and Rohit Kumar

progression, and increased risk of COVID-19 mortality. We conducted a single-center descriptive study with an aim to identify the effect of COVID-19 on treatment delay in patients receiving immune checkpoint inhibitors (ICI). Methods : A retrospective chart

Full access

Interventions for Financial Toxicity: More Crucial Than Ever in the Time of COVID-19

Thomas G. Knight

, effecting real change on patient circumstances falls to institutions. This is an especially important consideration in the current global environment. The COVID-19 pandemic represents an unprecedented health and economic crisis that will have far

Full access

CLO22-062: The Impact of COVID-19 Infection Among Genitourinary Cancer Patients in Los Angeles County: A Retrospective Analysis

Catherine Ly, Shiliang Zhang, Lauren Antrim, Nikhita Kathuria-Prakhash, Matthew Ebia, Varsha Tulpule, Anishka D'souza, and Gino Kim In

INTRODUCTION : Severe acute respiratory syndrome coronavirus (SARS-CoV-2) has affected over two hundred million people. Numerous studies have evaluated its impact on cancer patients in regards to COVID-19 severity and outcome. However, there is

Full access

QIM22-202: Cancer Diagnostic Center: A Response to the COVID-19 Pandemic to Improve Access to Diagnostic Testing

Raquel Reinbolt, Erin Heuser, Amanda Hrnicek, Tori Stucke, Julie Bicknell, Dareth Gilmore, and David Cohn

INTRODUCTION : During the COVID-19 pandemic, data suggests there was a significant decrease in the volume of cancer screening tests and number of cancer diagnoses made compared with historical trends. Given the association of late stage cancer

Full access

HSR22-157: We Answered the Call to Continue Colorectal Cancer Screening of Disparate Patients Despite COVID-19

Branden Middleton, Delecia Robinson, Lisa Scott, Tracie Lewis, Becky Eaddy, Annie Thibault, and Frank Berger

Colorectal cancer (CRC) screening of uninsured and medically underserved South Carolinians has been the goal of Colorectal Cancer Prevention Network (CCPN) for 12 years. Due to COVID19, screening was halted for 3 months. Two fecal immunochemical

Full access

HSR24-168: The Impact of the COVID-19 Pandemic on Cancer Treatments: A SEER Population Based-Analysis

Anirudh Goyal and Oxana Crysler

Background: The COVID-19 pandemic has limited access to healthcare resources in order to optimize isolation and minimize disease spread. The downstream effects on overall general health and well-being amidst the pandemic are often not discussed

Full access

BPI21-007: Physician Adherence to Treatment Guidelines Based on Priority Groups for Breast Cancer Patients During the COVID-19 Pandemic

Courtney Elisabeth Pisano, Janice A. Lyons, Gino Cioffi, Jill S. Barnholtz-Sloan, Joy Knight, Steven Maximuk, Megan E. Miller, Alberto J. Montero, Hannah Gilmore, and Eleanor E. Harris

Background: The COVID-19 pandemic presents unique challenges in breast cancer (BC) management. Clinicians at our institution along with members from COVID-19 breast cancer consortium, published and adopted practice guidelines assigning patients to